These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16296986)

  • 1. Detection of diagnostic and therapeutic radionuclides by US homeland security: a new travel hazard.
    Stockigt JR; Ballok Z; Kalff V
    Med J Aust; 2005 Nov; 183(10):552. PubMed ID: 16296986
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Tl-201 stress tests and homeland security.
    Gitler B
    J Nucl Cardiol; 2007; 14(6):904; author reply 904-5. PubMed ID: 18022120
    [No Abstract]   [Full Text] [Related]  

  • 3. Tl-201 stress tests and homeland security.
    Dauer LT; Williamson MJ; St Germain J; Strauss HW
    J Nucl Cardiol; 2007 Jul; 14(4):582-8. PubMed ID: 17679068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering radiation alarms after radioiodine treatment.
    Gangopadhyay KK; Sundram F; De P
    BMJ; 2006 Aug; 333(7562):293-4. PubMed ID: 16888306
    [No Abstract]   [Full Text] [Related]  

  • 5. An unusual case of Marine-Lenhart syndrome.
    El-Kaissi S; Kotowicz MA; Goodear M; Wall JR
    Thyroid; 2003 Oct; 13(10):993-4. PubMed ID: 14611711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Technical methodologic aspects of clinical dosimetry in radionuclide therapy].
    Denisenko ON; Ivanov VN; Drozdovskiĭ BIa; Nikulin IuP; Tiatte EG; Ivanova LF; Parshin VS
    Med Radiol (Mosk); 1990 Feb; 35(2):48-52. PubMed ID: 2179659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary thyroid carcinoma in cervical lymph nodes with vanished thyroid gland after ablation of Graves' disease by radioactive iodine.
    Hamdy O; Raafat S; Saleh GA; Atallah K; M Saleh M; Shebl AM; Hegazy MA
    Ann R Coll Surg Engl; 2019 May; 101(5):e122-e124. PubMed ID: 30854863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retreatment of Graves' disease with radioiodine 131I.
    Charkes ND
    J Nucl Med; 1999 Jan; 40(1):215-6. PubMed ID: 9935081
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies of radioiodine therapy for Graves' disease.
    Lind P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S453-7. PubMed ID: 12192545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease.
    Kidokoro-Kunii Y; Emoto N; Cho K; Oikawa S
    J Nippon Med Sch; 2006 Feb; 73(1):10-7. PubMed ID: 16538017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine treatment triggers security alarms: case report and review of literature.
    Paz-Filho GJ; Busnello JV; Licinio J; Zelmanovitz F
    J Nucl Med; 2008 Feb; 49(2):337. PubMed ID: 18245744
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease.
    Santiago JF; Jana S; El-Zeftawy H; Naddaf S; Abdel-Dayem HM
    Clin Nucl Med; 1999 Sep; 24(9):714-5. PubMed ID: 10478760
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.
    Tay WL; Tong AKT; Hui KYD; Tang YLC; Chng CL
    Hell J Nucl Med; 2017; 20(3):227-231. PubMed ID: 29177260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipitous detection of thyroid carcinoma in a patient with Graves' disease.
    Ahmad M; Johns W; Gupta SM
    Clin Nucl Med; 1999 Jan; 24(1):76. PubMed ID: 9890508
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalization of radioiodine treatment for Graves' disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass.
    Orsini F; Traino AC; Grosso M; Guidoccio F; Boni G; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):496-502. PubMed ID: 23358401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of thyrotoxicosis.
    Sipos JA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1-2. PubMed ID: 22938934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and pitfalls in thyroid uptake measurements with iodine-131.
    Kiratli PO; Gedik GK
    Hell J Nucl Med; 2008; 11(3):187-8. PubMed ID: 19081870
    [No Abstract]   [Full Text] [Related]  

  • 18. Contamination hazard due to iodine-131 therapy for thyrotoxicosis.
    Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
    Eur J Nucl Med; 1999 Dec; 26(12):1632. PubMed ID: 10638420
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating and managing patients with thyrotoxicosis.
    Campbell K; Doogue M
    Aust Fam Physician; 2012 Aug; 41(8):564-72. PubMed ID: 23145395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves disease mimicking solitary autonomous nodule at scintigraphy.
    Marui S; Augusto GA; Watanabe T
    Clin Nucl Med; 2012 Mar; 37(3):287-8. PubMed ID: 22310259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.